Analysis
Opinion

China’s Zero-COVID Policy a Shield for Windfall Revenues for Local Governments, Gene Companies

China’s Zero-COVID Policy a Shield for Windfall Revenues for Local Governments, Gene Companies
Medical workers take swab samples from residents to be tested for the COVID-19 coronavirus, in a street in Wuhan in China's central Hubei province on May 15, 2020. STR/AFP via Getty Images
David Chu
&
|Updated:
0:00
News Analysis
Two crucial pillars of the Chinese Communist Party’s (CCP) zero-COVID policy, intensive testing and lockdowns, have formed a huge chain of interests that have depleted the state treasury and sacrificed people’s livelihoods, according to China expert Henghe.
David Chu is a London-based journalist who has been working in the financial sector for almost 30 years in major cities in China and abroad, including South Korea, Thailand, and other Southeast Asian countries. He was born in a family specializing in Traditional Chinese Medicine and has a background in ancient Chinese literature.
Related Topics